Rf. Waller et al., NUCLEAR-ENCODED PROTEINS TARGET TO THE PLASTID IN TOXOPLASMA-GONDII AND PLASMODIUM-FALCIPARUM, Proceedings of the National Academy of Sciences of the United Statesof America, 95(21), 1998, pp. 12352-12357
A vestigial, nonphotosynthetic plastid has been identified recently in
protozoan parasites of the phylum Apicomplexa. The apicomplexan plast
id, or ''apicoplast,'' is indispensable, but the complete sequence of
both the Plasmodium falciparum and Toxoplasma gondii apicoplast genome
s has offered no clue as to what essential metabolic function(s) this
organelle might perform in parasites. To investigate possible function
s of the apicoplast, we sought to identify nuclear-encoded genes whose
products are targeted to the apicoplast in Plasmodium and Toxoplasma.
We describe here nuclear genes encoding ribosomal proteins S9 and L28
and the fatty acid biosynthetic enzymes acyl carrier protein (ACP), b
eta-ketoacyl-ACP synthase III (FabH), and beta-hydroxyacyl-ACP dehydra
tase (FabZ). These genes show high similarity to plastid homologues, a
nd immunolocalization of S9 and ACP verifies that the proteins accumul
ate in the plastid. All the putatively apicoplast-targeted proteins be
ar N-terminal presequences consistent with plastid targeting, and the
ACP presequence is shown to be sufficient to target a recombinant gree
n fluorescent protein reporter to the apicoplast in transgenic T. gond
ii, Localization of ACP, and very probably FabH and FabZ, in the apico
plast implicates fatty acid biosynthesis as a likely function of the a
picoplast. Moreover, inhibition of P. falciparum growth by thiolactomy
cin, an inhibitor of FabH, indicates a vital role for apicoplast fatty
acid biosynthesis. Because the fatty acid biosynthesis genes identifi
ed here are of a plastid/bacterial type, and distinct from those of th
e equivalent pathway in animals, fatty acid biosynthesis is potentiall
y an excellent target for therapeutics directed against malaria, toxop
lasmosis, and other apicomplexan-mediated diseases.